PDI inks deal with 'top-five' pharma company

Share this article:
PDI has inked a deal with an undisclosed “top-five pharmaceutical company” expected to generate $23 million in revenue for the contract sales firm over its one-year term. PDI said the deal will target primary care physicians and specialty audiences.
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.